Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Long COVID Syndrome: early-phase trial registry
3 of 3 indexed Long COVID Syndrome trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Long COVID Syndrome: 3 US clinical trials tracked, 3 recruiting.
Long COVID Syndrome is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is ImmunityBio, running 1 of these trials.
Enrollment posture brief
Registry condition long-covid-syndrome
OPEN 3 | RECR 100% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Long COVID Syndrome lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Long COVID Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Long COVID Syndrome is recruiting above its size-band peers.
3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
University of New Mexi
NCT06940609
A Study to Examine Anktiva for the Treatment of COVID-19.
ImmunityBio
NCT07123727
Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
University of Louisville
NCT06883513
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Long COVID Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Long COVID Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Long COVID Syndrome page
3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Long COVID Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- ImmunityBio sponsors the most Long COVID Syndrome trials on record, review their full trial history before evaluating a specific study. See ImmunityBio's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Long COVID Syndrome condition card totals 3 registered trials; most-linked intervention Anktiva; top US site state New Mexico. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.